Clinical Trial 23955

• Overview

  Study Title:

  A RANDOMIZED PHASE II TRIAL OF ENASIDENIB-BASED THERAPIES VERSUS CEDAZURIDINE DECITABINE IN HIGHER-RISK IDH2-MUTATED MYELODYSPLASTIC SYNDROME: A MYELOMATCH SUB-STUDY

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.